ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epigenetics"

  • Abstract Number: 2876 • 2013 ACR/ARHP Annual Meeting

    Key Rheumatoid Arthritis-Associated Pathogenic Pathways Revealed By Integrative Analysis Of RA Omics Datasets

    John Whitaker1, Wei Wang2 and Gary S. Firestein3, 1Chemistry, UCSD School of Medicine, La Jolla, CA, 2Chemistry, UCSD, La Jolla, CA, 3Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose:   Genome-wide analysis of RA has independently evaluated DNA sequence variation, differential RNA expression, and differential DNA methylation. Each approach alone implicates promising pathways…
  • Abstract Number: 1426 • 2013 ACR/ARHP Annual Meeting

    Inhibition Of Spermidine/Spermine N1-Acetyltransferase Activity – a New Therapeutical Concept In Rheumatoid Arthritis

    Emmanuel Karouzakis1, Astrid Jungel1, Beat A. Michel2, Renate E. Gay3, Steffen Gay1 and Michel Neidhart4, 1Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland, 2Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland, 4Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose: Spermine/spermidine N1-acetyltransferase (SSAT1) and polyamine modulating factor 1 (PMF1) are increased in rheumatoid arthritis synovial fibroblasts (RASF). Since PMF1 regulates the expression of SSAT1,…
  • Abstract Number: 2736 • 2013 ACR/ARHP Annual Meeting

    High Density Microarray Analysis Identifies Novel Differentially Expressed Long Noncoding RNAs In Rheumatoid Arthritis Synovial Fibroblasts

    Mojca Frank Bertoncelj1, Michelle Trenkmann1, Christoph Kolling2, Beat A. Michel3, Renate E. Gay4 and Steffen Gay1, 1Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland, 2Schultess Clinic, Zurich, Switzerland, 3Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 4Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland

    Background/Purpose: Long noncoding RNAs (lncRNAs) have emerged as key regulators of gene expression. Recently, several new susceptibility loci were identified for rheumatoid arthritis (RA), mapping…
  • Abstract Number: 1380 • 2013 ACR/ARHP Annual Meeting

    Histone Modifications In The Interluekin-6 Gene Promoter Region Of Rheumatoid Arthritis Synovial Fibroblasts

    Takuma Tsuzuki Wada1,2, Yasuto Araki1,2, Kazuhiro Yokota1, Fumihiko Miyoshi1, Kojiro Sato1 and Toshihide Mimura1,2, 1Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan, 2Project Research Division, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan

    Background/Purpose: , Rheumatoid arthritis (RA) is a disease of unknown origin, which develops continuous inflammation and progressive joint destruction resulting from an autoimmune response mainly…
  • Abstract Number: 2724 • 2013 ACR/ARHP Annual Meeting

    cAMP Responsive Element Modulator (CREM)α Governs CD8 Expression and Contributes to the Generation of CD3+CD4–CD8– T Cells in Lupus

    Christian M. Hedrich1, José C. Crispín1, Thomas Rauen1, Christina Ioannidis1, Tomohiro Koga2, Noe Rodriguez Rodriguez2, Sokratis A. Apostolidis3, Vasileios C. Kyttaris2 and George C. Tsokos1, 1Medicine/Rheumatology, BIDMC, Harvard Medical School, Boston, MA, 2Medicine/Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 3Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Background/Purpose: CD3+CD4-CD8- "double negative" T cells are expanded in the peripheral blood of patients with systemic lupus erythematosus (SLE) and lupus-prone mice. Double negative T…
  • Abstract Number: 775 • 2013 ACR/ARHP Annual Meeting

    Cytokine-Mediated Repression Of The Lncrna Hotair Enhances Intracellular Signaling and The Expression Of Adhesion Molecules In Synovial Fibroblasts

    Michelle Trenkmann1, Mojca Frank Bertoncelj1, Matthias Brock2, Christoph Kolling3, Renate E. Gay4, Beat A. Michel5, Diego Kyburz1, Lars C. Huber2 and Steffen Gay1, 1Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland, 2Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland, 3Schultess Clinic, Zurich, Switzerland, 4Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland, 5Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose: Rheumatoid arthritis (RA) synovial fibroblasts (SF) are characterized by a stably activated phenotype which is, at least in part, because of the epigenetic inheritance…
  • Abstract Number: 2731 • 2013 ACR/ARHP Annual Meeting

    An Acetyl-Histone Mimetic Blocks Proinflammatory Activation Of Rheumatoid Arthritis Fibroblast-Like Synoviocytes

    P. A. Kabala1, A.M. Grabiec1, C. Angiolilli1, Nicholas Smithers2, Jason Witherington3, Paul Peter Tak4, Rabinder Prinjha3 and Kris A. Reedquist5, 1Department of Experimental Immunology, Department of Clinical Immunology and Rheumatology Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Immuno Inflammation, GlaxoSmithKline, Stevenage, United Kingdom, 3GlaxoSmithKline, Stevenage, United Kingdom, 4Academic Medical Center / University of Amsterdam, Department of Clinical Immunology and Rheumatology & GlaxoSmithKline, Amsterdam, Netherlands, 5Department of Experimental Immunology and Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: Genetic backgrounds and environmental factors do not completely explain the etiology of disease and predisposition to rheumatoid arthritis (RA), and increasing attention has turned…
  • Abstract Number: 776 • 2013 ACR/ARHP Annual Meeting

    Tumor Necrosis Factor Alpha Modifies Chromatin Landscape and Amplifies Inflammatory Responses To Subsequent Stimuli In Synovial Fibroblasts

    Angela Lee1, Lionel B. Ivashkiv2 and George D. Kalliolias1, 1Medicine, Hospital for Special Surgery, New York, NY, 2Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: Fibroblast-like synoviocytes (FLS) cross-talk with macrophages (Mf) during the course of rheumatoid arthritis (RA). Our group has shown that TNFa, primarily Mf-derived within synovium,…
  • Abstract Number: 2734 • 2013 ACR/ARHP Annual Meeting

    Epigenetic Control Of a Gene Regulatory Network Associated With Experimental Autoimmune Arthritis and Rheumatoid Arthritis

    Andras Vida1, Janos Gal2, Gyorgyi Soos2, Attila Balog3, Laszlo G. Puskas4, Katalin Mikecz1, Tibor T. Glant1 and Tibor A. Rauch1, 1Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 2Rheumatology, Bacs-Kiskun County Hospital, Kecskemet, Hungary, 3Rheumatology, Albert Szent-Gyorgyi University, Szeged, Hungary, 4Laboratory of Functional Genomics, Biological Research Center, Szeged, Hungary

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune inflammatory disorder that mainly affects the synovial joints, leading to destruction of articular cartilage and bone. There is…
  • Abstract Number: 2735 • 2013 ACR/ARHP Annual Meeting

    Integrative Analysis Of Multiple Omics Technologies Reveals a Novel Therapeutic Target For Rheumatoid Arthritis (RA)

    David L. Boyle1, John Whitaker2, Beatrix Bartok3, Wei Wang4 and Gary S. Firestein5, 1Div of Rheum, UCSD School of Medicine, La Jolla, CA, 2Chemistry, UCSD School of Medicine, La Jolla, CA, 3Rheumatology, UCSD School of Medicine, La Jolla, CA, 4Chemistry, UCSD, La Jolla, CA, 5Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose:   Identifying novel therapeutic targets for immune-mediated disease has become increasingly challenging. We used an unbiased method to integrate multiple “omics” methodologies and evaluate…
  • Abstract Number: 2697 • 2013 ACR/ARHP Annual Meeting

    Identification Of Genetic and Epigenetic Alterations In Spondyloarthritis

    Tibor A. Rauch1, Beata Tryniszewska1, Andras Vida1, Timea Ocsko1, Sandor Szanto2, Holly L. Rosenzweig3, Matthew A. Brown4, Gethin P Thomas5, Katalin Mikecz1 and Tibor T. Glant1, 1Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 2Rheumatology, University of Debrecen, Debrecen, Hungary, 3Oregon Health & Science University, Portland, OR, 4Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, Australia, 5Translational Reserch Institute, University of Queensland Diamantina Institute, Woolloongabba, Australia

    Background/Purpose: Ankylosing spondylitis (AS) is the prototypic spondyloarthritis and affects approximately 0.2-0.5% of the human population. It is estimated that genetic risk factors contribute >90%…
  • Abstract Number: 2519 • 2013 ACR/ARHP Annual Meeting

    A Systemic Lupus Erythematosus (SLE) Diagnostic Test Based On DNA Methylation Signatures From Peripheral Blood Mononuclear Cells

    David W. Anderson1, Robert Shoemaker2, Kurt Krummel3, Zachary Hornby4 and Jonathan E. Lim1, 1Research and Development, IGNYTA, Inc., San Diego, CA, 2Bioinformatics, IGNYTA, Inc., San Diego, CA, 3Research and Development-Assay Development, IGNYTA, Inc., San Diego, CA, 4Business Development, IGNYTA, Inc., San Diego, CA

    Background/Purpose: The heterogeneous nature of SLE and a lack of reliable biomarkers make SLE a challenge to classify in patients. A differential diagnosis of SLE…
  • Abstract Number: 2424 • 2013 ACR/ARHP Annual Meeting

    Investigation Of The Role Of Histone Deacetylases In Rheumatoid Arthritis Synovial Fibroblasts

    Sarah Hawtree1, Munitta Muthana1, Sarah Aynsley1, J. Mark Wilkinson2 and Anthony G. Wilson3, 1Infection and Immunity, University of Sheffield, Sheffield, United Kingdom, 2Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, United Kingdom, 3Infection & Immunity, University of Sheffield, Sheffield, United Kingdom

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, autoimmune, inflammatory disease that affects synovial joints. A key characteristic of RA is hyperplasia of fibroblast-like synoviocytes (FLS).…
  • Abstract Number: 993 • 2012 ACR/ARHP Annual Meeting

    A Genome-Wide DNA Methylation Analysis Reveals Different Methylation Patterns in the OA Disease

    Ignacio Rego-Pérez1, Juan Fernandez-Tajes2, Mercedes Fernandez-Moreno2, Maria Tamayo Novas3, Alejandro Mosquera Rey3, Natividad Oreiro2, Carlos Fernandez-Lopez2, Jose Luis Fernandez Garcia3 and Francisco J. Blanco2, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 2INIBIC-Hospital Universitario A Coruña. Rheumatology Division. Genomic Group, A Coruña, Spain, 3INIBIC-Hospital Universitario A Coruña. Genetic Deparment., A Coruña, Spain

     Background/Purpose: DNA methylation is a basic mechanism involved in epigenetic regulation that affects gene transcription by the addition of a methyl group to the cytosine…
  • Abstract Number: 873 • 2012 ACR/ARHP Annual Meeting

    Imbalance Between Histone Acetyl Transferase and Histone Deacteylase Activities and Modulation of HDAC Activity and Tnfa Production by HDAC Inhibitors in Patients with Ankylosing Spondylitis or Rheumatoid Arthritis

    Eric Toussirot1, Wasim Abbas2, Kashif Aziz Khan3, Marion Tissot4, Alicia Jeudy2, Lucile Baud2, Ewa Bertolini5, Daniel Wendling6, Georges Herbein7 and CIC Biotherapy8, 1Université de Franche Comté , CHRU, CIC Biotherapy 506 and Rheumatology and EA 4266 Pathogens and Inflammation, Besançon, France, 2University of Franche Comté, EA 4266 Pathogens and Inflammation, Besançon, France, 3University of Franche Comté, EA Pathogens and Inflammation, Besançon, France, 4EA Pathogens and Inflammation, EA 4266 Pathogens and Inflammation, Besançon, France, 5University Hospital, Rheumatology, Besançon, France, 6Service de Rhumatologie, Minjoz University Hospital, Besancon, France, 7University Hospital, Virology and EA 4266 Pathogens and Inflamamtion, Besançon, France, 8University Hospital, Besançon, France

    Background/Purpose: TNFa is a major cytokine involved in conditions such as ankylosing spondylitis (AS) and rheumatoid arthritis (RA). Epigenetic regulation corresponds to different processes including…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology